BioShares Biotechnology Profile

USD 0.33  0.99%

BioShares Biotechnology Summary

BioShares Biotechnology Clinical Trials [BBC] is traded in USA and was established on February 22, 2018. The fund is classified under Health category within Bio Shares family. BioShares Biotechnology Clinical Trials currently have 31.18 M in assets under management (AUM). , while the total return for the last 3 years was 1.36%.
Check BioShares Biotechnology Probability Of Bankruptcy

Geographic Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Advisory Services Network LlcFund Units108.4 K3.1 M
View BioShares Biotechnology Diagnostics

BioShares Biotechnology Risk Profiles

BioShares Biotechnology Technical Analysis

The output start index for this execution was zero with a total number of output elements of seventeen. BioShares Biotechnology Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe BioShares Biotechnology price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

BioShares Biotechnology Against Markets

Current Ratings

BioShares Biotechnology 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for BioShares Biotechnology Clinical Trials are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. more
NameBioShares Biotechnology Clinical Trials
Macroaxis Advice
InstrumentUSA Etf ETF Directory
RegionNorth America
Investment IssuerBioShares
ExchangeNASDAQ General Markets
Etf FamilyBio Shares
Fund CategorySector
Portfolio ConcentrationHealth Care
Contact Number888 383 0553
CurrencyUSD - US Dollar
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-17
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management41.49 Million
Average Trading Valume28,032
Asset TypeEquity
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndOctober 31
ExchangeNYSE Arca, Inc.
Number of Constituents84.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas